All episodes
Forging Smarter Clinical CRO Partnerships - Fairooz Kabbinavar, REV Clinical
CRL - Every Moment Matters: Developing an N-of-1 ASO for a Child with an Ultra-Rare Disease
CRL - Every Moment Matters: A Case for Adaptive Immunogenicity Testing
CRL - Every Moment Matters: The Power of Study Director–Advisor Partnerships
CRL - Every Moment Matters: Getting Better Insights on Target and off Target Biology
CRL - Every Moment Matters: How Integrated Teams De-Risk the Path from Discovery to IND
CRL - Every Moment Matters: DMPK’s Role in Making Better Drugs and Better Decisions
Biotech Showcase Readies as Biotech Stocks and Deals Pick Up - Sara Demy, Demy-Colton
CRL - Every Moment Matters: Integrating AI into Drug Discovery
CRL - Every Moment Matters: Transforming Discovery with Organoids
CRL - Every Moment Matters: How NAMs Are Rewriting the Rules of Antibody Discovery
What It Takes for Life Science Innovation to Thrive - Tim Scott, Biocom
CRL - Every Moment Matters: Navigating the Complexities of Drug Discovery
A Moment of Opportunity for European Biotech - EBD Group
Surviving and Thriving in the Long Biotech Winter - Kevin Sarney, Charles River CFO
Leveraging Synergies: How a Merger Provides Speed, Flexibility, and a Unified Offering for Customers
Understanding the True Risk of Biotech Shareholder Lawsuits - Mike Milligan, C3 Risk & Insurance
Why Biotech CEOs Should Prepare Now for All Opportunities - Gregg Beloff, Danforth Advisors
Charles River Labs - ICH M12: How Will New Regulatory Harmonization Impact Drug Developers?
Setting the Stage for Productive Partnering Talks During JPM Week
Innovating the Development of Therapies for N-of-1 Patients - Roxana Redis, Charles River LAbs
Overcoming Neuroscience Challenges Using Complex Cell Models - Malika Bsibsi, Charles River Labs
Gazing into the Future of Biotechnology - Sara Demy, Demy-Colton
Augmented Science: AI’s Place in Drug Discovery - David Clark, Charles River Labs
Confessions of a Hit Man: Matching Target Strategies to the Need - Rob Howes, Charles River Labs
Why Failure Can Be a Faster Path to Success - Sarah Gould, Charles River Labs
Driving Deeper Insights into Structure-Based Drug Design with Cryo-EM - Charles River Labs
Solving Major Bottlenecks in Genetic Medicine and SynBio - Matt Hill, Elegen
Using Early Biomarker Discovery to Secure Clinical Success - Stefan Kostense, Charles River Labs
Rethinking Mass Spectrometry for Drug Discovery - Zack Gurard-Levin, Charles River Labs
Navigating the Growing Challenges for Biotech CFOs - - Kevin Sarney, Charles River CFO
De-Risking Therapeutic Candidates with Off-Target Screening - Mark Aspinall-O’Dea, CRL
Rapid Diagnostic Test Innovators Look to the Future - DCN Dx
Leveraging Technology to Avoid Costly Clinical Trial Delays - Arthur D. Little
Investors and Innovators Gear Up for Biotech Showcase - Tina Elder, EBD Group
Remaining Capital-Efficient While Accessing Seasoned Talent - Ramani Varanasi, Danforth Advisors
Delivering Research-Ready Vivaria with Speed, Scalability, Flexibility - Julie Freebersyser, CRADL
Keeping Employees Engaged and Productive During Difficult Financial Times - Ann Darda, Danforth
Envisioning the Future of Healthcare - Sara Demy, Demy-Colton
Biotech in the City that Never Sleeps
A Region Where Biotech is a Capital Idea
A Home to Amazon, Starbucks, and Biotech Too
A Look at a Star-Studded Biotech Region
Addressing Drug Developer Challenges with Decentralized Clinical Trials
Pioneering Fully Programmable Medicines
Recruiting in a Competitive Market for Life Sciences Talent
How Biotechs Can Best Navigate through Tough Financial Times
Delivering Efficient and Flexible Infrastructure to Life Sciences Companies
The Biotech Showcase Readies for a Big Year
Life Sciences Executives Learn to Give Until It Hurts
Transforming Drug Discovery by Focusing on Cell Behavior
The Biotech Showcase Returns to San Francisco as a Hybrid Event
Keeping the Life Sciences Workplace Safe
The Write Stuff: Reinventing the Synthesis of DNA with Enzymes
How a Long Effort to Protect Against RSV May Lead to a Better COVID-19 Vaccine
An Innovative Approach to Treating Multi-Drug Resistant Bacterial Infections
The Environment for Life Sciences Dealmaking and How to Gain Leverage in Negotiations